Interaction of IL-2Rβ and γ <sub>c</sub> Chains with Jak1 and Jak3: Implications for XSCID and XCID

Sarah M. Russell(National Institutes of Health), James A. Johnston(Frederick National Laboratory for Cancer Research), Masayuki Noguchi(National Institutes of Health), Masaru Kawamura(Frederick National Laboratory for Cancer Research), Chris M. Bacon(Frederick National Laboratory for Cancer Research), Michael Friedmann(National Institutes of Health), Maria Berg(National Institutes of Health), Daniel W. McVicar(Frederick National Laboratory for Cancer Research), Bruce A. Witthuhn(St. Jude Children's Research Hospital), Olli Silvennoinen(St. Jude Children's Research Hospital), Armond S. Goldman(The University of Texas Medical Branch at Galveston), Frank C. Schmalstieg(The University of Texas Medical Branch at Galveston), James N. Ihle(St. Jude Children's Research Hospital), John J. O’Shea(Frederick National Laboratory for Cancer Research), Warren J. Leonard(National Institutes of Health)
Science
November 11, 1994
Cited by 656

Abstract

Interleukin-2 (IL-2) signaling requires the dimerization of the IL-2 receptor beta.(IL-2R beta) and common gamma (gamma c) chains. Mutations of gamma c can result in X-linked severe combined immunodeficiency (XSCID). IL-2, IL-4, IL-7 (whose receptors are known to contain gamma c), and IL-9 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases Jak1 and Jak3. Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations. Truncations of gamma c, and a gamma c, point mutation causing moderate X-linked combined immunodeficiency (XCID), decreased gamma c-Jak3 association. Thus, gamma c mutations in at least some XSCID and XCID patients prevent normal Jak3 activation, suggesting that mutations of Jak3 may result in an XSCID-like phenotype.


Related Papers

No related papers found

Powered by citation graph analysis